Inactive

DEA issues RFP Amendment 0001 to provide the Q&A response. DEA requires a contractor to conduct preclinical behavioral evaluations of several stimulant substances in comparison to appropriate controls... DEA issues RFP Amendment 0001 to provide the Q&A response. DEA requires a contractor to conduct preclinical behavioral evaluations of several stimulant substances in comparison to appropriate controls and reference standard for example, THC. Each compound shall be assessed for tetrad assay and drug discrimination studies. The vendor shall provide DEA with investigational study results and a description of the methodology used to conduct the investigation in the form of a study report based on the timeline specified in this statement of work (SOW),